In detection of RDD-related mutations, the presence of mutually exclusive KRAS and MAP2K1 mutations, which regulated MAPK/ERK signaling pathway, was found in 7 of 21 RDD cases [7]. The gene discussed is MAP2K1; the disease is sinus histiocytosis with massive lymphadenopathy.